Cryopyrin-Associated Periodic Syndrome Drug Pipeline Report 2024: Therapeutic Developments for Zydus Cadila, Novartis, Inflazome, Roche, Aclaris Therapeutics, and Mabpharm
April 25, 2024 07:43 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Cryopyrin-Associated Periodic Syndrome - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offeringThe global medical...
Interleukin-2 (IL-2) Inhibitor Drug Pipeline Research Report 2024
March 05, 2024 03:30 ET
|
Research and Markets
Dublin, March 05, 2024 (GLOBE NEWSWIRE) -- The "Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
ENSPRYNG Emerging Drug Insight and Market Forecast 2023- 2032
April 10, 2023 04:03 ET
|
Research and Markets
Dublin, April 10, 2023 (GLOBE NEWSWIRE) -- The "ENSPRYNG Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering."ENSPRYNG Emerging Drug Insight...
North America GMP Cell Therapy Consumables Market Report 2023: Growing Regulatory Approvals for Cell and Gene Therapy (CGT) Products Presents Opportunities
February 28, 2023 08:28 ET
|
Research and Markets
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "North America GMP Cell Therapy Consumables Market Forecast to 2028 - COVID-19 Impact and Regional Analysis" report has been added to ...
GMP Cell Therapy Consumables Global Market Report 2022: Featuring Sartorius, Thermo Fisher Scientific, Bio-Techne, FUJIFILM & More
January 03, 2023 06:38 ET
|
Research and Markets
Dublin, Jan. 03, 2023 (GLOBE NEWSWIRE) -- The "GMP Cell Therapy Consumables Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Cell Therapy, Process, and End Use" report has...
Outlook on the Systemic Scleroderma Treatment Global Market Report to 2028 - Size, Share, Outlook and Opportunity Analysis
May 04, 2022 06:28 ET
|
Research and Markets
Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Systemic Scleroderma Treatment Market, by Drug Class, by Disease Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share,...
Worldwide Interleukin Inhibitors Industry to 2026 - by Product Type, Application and Region
July 23, 2021 04:53 ET
|
Research and Markets
Dublin, July 23, 2021 (GLOBE NEWSWIRE) -- The "Global Interleukin Inhibitors Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The global Interleukin Inhibitors market is...
Global Gout Clinical Landscape Market 2020-2030 - AstraZeneca Leads Industry Sponsors with the Highest Overall Number of Clinical Trials
June 16, 2021 04:58 ET
|
Research and Markets
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Gout" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Gout market, comprising key...
Global Psoriasis Drugs Market Analysis and Demand Report 2021-2030: Rising Geriatric Population, Increasing Prevalence, Growing Awareness, Extensive Pipeline
June 03, 2021 06:53 ET
|
Research and Markets
Dublin, June 03, 2021 (GLOBE NEWSWIRE) -- The "Psoriasis Drugs Market Research Report: By Type, Mechanism of Action, Route of Administration - Global Industry Analysis and Demand Forecast to 2030"...
Study Identifies New Role of BioAegis’ ‘Inflammation Regulator’ Gelsolin Relevant for a Range of Inflammatory Diseases
April 08, 2021 18:58 ET
|
BioAegis Therapeutics
Gelsolin mitigates vascular damage by preventing release of IL-1β microparticles after trauma of high pressure and decompression. Gelsolin is non-immunosuppressive unlike current treatments to quell...